Gender differences in myocardial blood flow dynamics lipid profile and hemodynamic effects

Journal of the American College of Cardiology

Volumn 33, Issue 2, 1999, Pages 463-470

  Duvernoy, Claire S ^a   Meyer, Christian ^a   Seifert Klauss, Vanadin ^b   Dayanikli, Firat ^c   Matsunari, Ichiro ^a   Rattenhuber, Judith ^b   Höss, Cornelia ^b   Graeff, Henner ^b   Schwaiger, Markus ^a,b  

^a TUMK rechts der Isar   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY RISK; FEMALE; HEART MUSCLE BLOOD FLOW; HEMODYNAMICS; HUMAN; HYPERLIPIDEMIA; ISCHEMIC HEART DISEASE; LIPOPROTEIN BLOOD LEVEL; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; TRIACYLGLYCEROL BLOOD LEVEL;

ADENOSINE; CHOLESTEROL; CORONARY CIRCULATION; CORONARY DISEASE; FEMALE; FOLLOW-UP STUDIES; HEART RATE; HUMANS; HYPEREMIA; HYPERLIPIDEMIAS; LIPIDS; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; POSTMENOPAUSE; PROGNOSIS; REGIONAL BLOOD FLOW; REST; RISK FACTORS; SEX CHARACTERISTICS; TOMOGRAPHY, EMISSION-COMPUTED; TRIGLYCERIDES; VASODILATOR AGENTS;

EID: 0033081095     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(98)00575-0     Document Type: Article

References (31)

1. Scandinavian Simvastatin Survival Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease. Lancet. 344:1994;1383-1389.
2. Shepherd J., Cobbe S.M., Ford I., et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia West of Scotland Coronary Prevention Study Group. [see comments] N Engl J Med. 333:1995;1301-1307.
3. Treasure C.B., Klein J.L., Weintraub W.S., et al. Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease. [see comments] N Engl J Med. 332:1995;481-487.
4. Dayanikli F., Grambow D., Muzik O., Mosca L., Rubenfire M., Schwaiger M. Early detection of abnormal coronary flow reserve in asymptomatic men at high risk for coronary artery disease using positron emission tomography. Circulation. 90:1994;808-817.
5. Yokoyama I., Ohtake T., Momomura S., Nishikawa J., Sasaki Y., Omata M. Reduced coronary flow reserve in hypercholesterolemic patients without overt coronary stenosis. Circulation. 94:1996;3232-3238.
6. Czernin J., Mueller P., Chan S., et al. Influence of age and hemodynamics on myocardial blood flow and flow reserve. Circulation. 88:1993;62-69.
7. Kannel W.B., Hjortland M.C., McNamara P.M., Gordon T. Menopause and risk of cardiovascular disease the Framingham study. Ann Intern Med. 85:1976;447-452.
8. Jacobs D. Jr, Mebane I.L., Bangdiwala S.I., Criqui M.H., Tyroler H.A. High density lipoprotein cholesterol as a predictor of cardiovascular disease mortality in men and women the follow-up study of the Lipid Research Clinics Prevalence Study. Am J Epidemiol. 131:1990;32-47.
9. 13N-labeled L-glutamic acid Radiology. 116:1975;127-132.
10. Hutchins G., Caraher J., Raylman R. A region of interest strategy for minimizing resolution distortions in quantitative myocardial PET studies. J Nucl Med. 33:1992;1243-1250.
11. Muzik O., Beanlads R., Wolfe E., Hutchins G., Schwaiger M. Automated region definition for cardiac nitrogen-13-ammonia PET imaging. J Nucl Med. 34:1993;336-344.
12. Muzik O., Beanlands R., Hutchins G., Mangner T., Nguyen N., Schwaiger M. Validation of nitrogen-13-ammonia tracer kinetic model for quantification of myocardial blood flow using PET. J Nucl Med. 34:1993;83-91.
13. Laubenbacher C., Rothley J., Sitomer J., et al. An automated analysis program for the evaluation of cardiac PET studies initial results in the detection and localization of coronary artery disease using N-13 ammonia. J Nucl Med. 34:1993;968-978.
14. Kannel W.B. Metabolic risk factors for coronary heart disease in women perspective from the Framingham Study. Am Heart J. 114:1987;413-419.
15. Criqui M.H., Heiss G., Cohn R., et al. Plasma triglyceride level and mortality from coronary heart disease. [see comments] N Engl J Med. 328:1993;1220-1225.
16. Barrett-Connor E. Sex differences in coronary heart disease. Why are women so superior? Circulation. 95:1997;252-264.
17. Farb A., Burke A.P., Tang A.L., et al. Coronary plaque erosion without rupture into a lipid core a frequent cause of coronary thrombosis in sudden coronary death. Circulation. 93:1996;1534-1563.
18. Burke A.P., Farb A., Malcom G.T., Liang Y., Smialek J., Virmani R. Coronary risk factors and plaque morphology in men with coronary disease who died suddenly. N Engl J Med. 336:1997;1276-1282.
19. Davies M.J. The composition of coronary artery plaques. N Engl J Med. 336:1997;1312-1314.
20. Yokoyama I., Murakami T., Ohtake T., et al. Reduced coronary flow reserve in familial hypercholesterolemia. J Nucl Med. 37:1996;1937-1942.
21. Seiler C., Hess O.M., Buechi M., Suter T.M., Krayenbuehl H.P. Influence of serum cholesterol and other coronary risk factors on vasomotion of angiographically normal coronary arteries. Circulation. 88:1993;2139-2148.
22. Wilson R., Wyche K., Christensen B., Zimmer S., Laxson D. Effects of adenosine on human coronary arterial circulation. Circulation. 82:1990;1595-1606.
23. Cerqueira M.D., Verani M.S., Schwaiger M., Heo J., Iskandrian A.S. Safety profile of adenosine stress perfusion imaging results from the Adenoscan Multicenter Trial Registry. J Am Coll Cardiol. 23:1994;384-389.
24. McGinn A., White C., Wilson R. Interstudy variability of coronary flow reserve influence of heart rate, arterial pressure, and ventricular preload. Circulation. 81:1990;1319-1330.
25. 1 adrenergic receptor blockade on myocardial blood flow and vasodilatory capacity. J Nucl Med. 38:1997;442-446.
26. Nagamachi S., Czernin J., Kim A.S., et al. Reproducibility of measurements of regional resting and hyperemic myocardial blood flow assessed with PET. J Nucl Med. 37:1996;1626-1631.
27. Nichols W.W., O'Rourke M.F., Avolio A.P., Yaginuma T., Murgo J.P. Effects of age on ventricular vascular coupling. Am J Cardiol. 55:1984;1179-1184.
28. Iskandrian A.S. Are the differences between adenosine and dipyridamole clinically relevant? J Nucl Cardiol. 3:1996;281-283.
29. Rubanyi G., Romero J., Vanhoutte P. Flow-induced release of endothelium-derived relaxing factor. Am J Physiol. 240:1986;H767-H774.
30. Muzik O., Paridon S.M., Singh T.P., Morrow W.R., Dayanikli F., DiCarli M.F. Quantification of myocardial blood flow and flow reserve in children with a history of Kawasaki disease and normal coronary arteries using positron emission tomography. J Am Coll Cardiol. 28:1996;757-762.
31. 13N]ammonia and positron computed tomography. Am J Cardiol. 49:1982;1197-1207.